The upper pulmonary veins (PVs) are responsible for the majority of atrial fibrillation (AF) triggering foci, whereas the inferior PVs are more difficult to ablate and prone to postablation ostial ...

Subjects in the study were monitored using the LUX-Dx insertable cardiac monitor system to detect arrhythmia recurrence.

These foci are commonly in the superior pulmonary veins; this is an important factor in the electrophysiologic approach to atrial fibrillation, known as pulmonary vein isolation. Less commonly ...

PFA is a newer Afib ablation modality touted as reducing the risk of damaging nearby collateral structures, compared with ...

Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the ...

Kardium today announced one-year clinical trial results for its Globe PF pulsed field ablation (PFA) system for treating AFib ...

Omny-IRE data demonstrated the investigational OMNYPULSETM Platform achieved 100% acute success and 84.5% pulmonary vein isolation (PVI) durabilit ...

"Second, PFA may yield more durable lesions, thereby reducing pulmonary-vein reconnections ... growing body of evidence supporting the use of PFA for the treatment of atrial fibrillation." "It shows ...

Boston Scientific (BSX) announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial ...

One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...

Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to ...